Medicare Payment Advisory Commission Nominations, 2937 [2015-00759]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 13 / Wednesday, January 21, 2015 / Notices
of the final rule. DOE’s final rule can be
found at https://www.regulations.gov
(docket number EE–RM/STD–02–112 or
RIN number 1904–AC13).
Dated: January 13, 2015.
Kevin Kampschroer,
Federal Director, Office of Federal HighPerformance Green Buildings, Office of
Government-wide Policy, U.S. General
Services Administration.
[FR Doc. 2015–00861 Filed 1–20–15; 8:45 am]
BILLING CODE 6820–14–P
GOVERNMENT ACCOUNTABILITY
OFFICE
Medicare Payment Advisory
Commission Nominations
Government Accountability
Office (GAO).
ACTION: Notice on letters of nomination.
AGENCY:
The Balanced Budget Act of
1997 established the Medicare Payment
Advisory Commission (MedPAC) and
gave the Comptroller General
responsibility for appointing its
members. For appointments to MedPAC
that will be effective May 1, 2015, I am
announcing the following: Letters of
nomination and resumes should be
submitted by March 13, 2015 to ensure
adequate opportunity for review and
consideration of nominees prior to the
appointment of new members.
ADDRESSES:
Email: MedPACappointments@
gao.gov
Mail: U.S. GAO, Attn: MedPAC
Appointments, 441 G Street NW.,
Washington, DC 20548
FOR FURTHER INFORMATION CONTACT:
GAO Office of Public Affairs, (202) 512–
4800.
42 U.S.C. 1395b–6.
SUMMARY:
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2015–00759 Filed 1–20–15; 8:45 am]
BILLING CODE 1610–02–M
asabaliauskas on DSK5VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Presidential Commission for
the Study of Bioethical Issues, Office of
the Assistant Secretary for Health,
Office of the Secretary, Department of
Health and Human Services,
AGENCY:
VerDate Sep<11>2014
18:58 Jan 20, 2015
Jkt 235001
ACTION:
Notice of meeting.
The Presidential Commission
for the Study of Bioethical Issues (the
Commission) will conduct its twentieth
meeting on February 5–6, 2015. At this
meeting, the Commission will conclude
discussions related to the BRAIN
Initiative and ongoing work in
neuroscience, and begin discussions
about the ethical considerations and
implications of public health emergency
response with a focus on the current
Ebola virus disease epidemic.
DATES: The meeting will take place
Thursday, February 5, 2015, from 9 a.m.
to approximately 5:30 p.m., and Friday,
February 6, 2015, from 9 a.m. to
approximately 12 p.m.
ADDRESSES: Hamilton Crowne Plaza
Hotel, 1001 14th St. NW., Washington,
DC 20005.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues, 1425
New York Avenue NW., Suite C–100,
Washington, DC 20005. Telephone:
202–233–3960. Email: Hillary.Viers@
bioethics.gov. Additional information
may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
twentieth meeting of the Commission.
The meeting will be open to the public
with attendance limited to space
available. The meeting will also be
webcast at www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an expert panel of
not more than 13 members who are
drawn from the fields of bioethics,
science, medicine, technology,
engineering, law, philosophy, theology,
or other areas of the humanities or
social sciences. The Commission
advises the President on bioethical
issues arising from advances in
biomedicine and related areas of science
and technology. The Commission seeks
to identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda items for the
Commission’s twentieth meeting are to
discuss the BRAIN Initiative and
ongoing work in neuroscience, and the
ethical considerations and implications
of public health emergency response
with a focus on the current Ebola virus
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
2937
disease epidemic. The draft meeting
agenda and other information about the
Commission, including information
about access to the webcast, will be
available at www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful debate of opposing views
and active participation by citizens in
public exchange of ideas enhances
overall public understanding of the
issues at hand and conclusions reached
by the Commission. The Commission is
particularly interested in receiving
comments and questions during the
meeting that are responsive to specific
sessions. Written comments will be
accepted at the registration desk and
comment forms will be provided to
members of the public in order to write
down questions and comments for the
Commission as they arise. To
accommodate as many individuals as
possible, the time for each question or
comment may be limited. If the number
of individuals wishing to pose a
question or make a comment is greater
than can reasonably be accommodated
during the scheduled meeting, the
Commission may make a random
selection.
Written comments will also be
accepted in advance of the meeting and
are especially welcome. Please address
written comments by email to info@
bioethics.gov, or by mail to the
following address: Public Commentary,
Presidential Commission for the Study
of Bioethical Issues, 1425 New York
Avenue NW., Suite C–100, Washington,
DC 20005. Comments will be made
publicly available, including any
personally identifiable or confidential
business information that they contain.
Trade secrets should not be submitted.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 233–3960, or email at
Esther.Yoo@bioethics.gov in advance of
the meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Dated: January 5, 2015.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2015–00801 Filed 1–20–15; 8:45 am]
BILLING CODE 4150–28–P
E:\FR\FM\21JAN1.SGM
21JAN1
]]>Agencies
[Federal Register Volume 80, Number 13 (Wednesday, January 21, 2015)]
[Notices]
[Page 2937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00759]
=======================================================================
-----------------------------------------------------------------------
GOVERNMENT ACCOUNTABILITY OFFICE
Medicare Payment Advisory Commission Nominations
AGENCY: Government Accountability Office (GAO).
ACTION: Notice on letters of nomination.
-----------------------------------------------------------------------
SUMMARY: The Balanced Budget Act of 1997 established the Medicare
Payment Advisory Commission (MedPAC) and gave the Comptroller General
responsibility for appointing its members. For appointments to MedPAC
that will be effective May 1, 2015, I am announcing the following:
Letters of nomination and resumes should be submitted by March 13, 2015
to ensure adequate opportunity for review and consideration of nominees
prior to the appointment of new members.
ADDRESSES:
Email: MedPACappointments@gao.gov
Mail: U.S. GAO, Attn: MedPAC Appointments, 441 G Street NW.,
Washington, DC 20548
FOR FURTHER INFORMATION CONTACT: GAO Office of Public Affairs, (202)
512-4800.
42 U.S.C. 1395b-6.
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2015-00759 Filed 1-20-15; 8:45 am]
BILLING CODE 1610-02-M
